Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (31)

2024

  1. Gut Microbiota Signatures with Potential Clinical Usefulness in Colorectal and Non-Small Cell Lung Cancers

    Biomedicines, Vol. 12, Núm. 3

2023

  1. Implementation of a perioperative care App in elective thoracic surgery

    Cirugia Espanola, Vol. 101, Núm. 4, pp. 265-273

  2. Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases

    Biomedicines, Vol. 11, Núm. 12

  3. The Use of Fissios App© as a Complement to a Face-to-Face Respiratory Physiotherapy Program versus an Attendance-Only Face-to-Face Physiotherapy Program in Patients Scheduled for Thoracic Surgical Procedures Reduces the Risk of Developing Postoperative Pulmonary Complications—A Quasi-Experimental Study

    Journal of Clinical Medicine, Vol. 12, Núm. 21

2021

  1. Physicians’ viewpoints on faculty anatomists and dissection of human bodies in the undergraduate medical studies

    Annals of Anatomy, Vol. 238

2019

  1. Implementing a distress screening program in a thoracic surgery service

    Cirugia Espanola, Vol. 97, Núm. 5, pp. 275-281

  2. Perioperative and Periprocedural Management of Antithrombotic Therapy

    Archivos de Bronconeumologia, Vol. 55, Núm. 5, pp. 229-230

  3. Perioperative and Periprocedural Management of Antithrombotic Therapy

    Archivos de Bronconeumologia

  4. Thoracic cystic lymphangioma. Thoracoscopic surgery

    Revista de Patologia Respiratoria, Vol. 22, Núm. 2, pp. 72-74

2018

  1. Combined Hepatic and Pulmonary Metastasectomies From Colorectal Carcinoma. Data From the Prospective Spanish Registry 2008–2010

    Archivos de Bronconeumologia, Vol. 54, Núm. 4, pp. 189-197

2015

  1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338

  2. Telomere length and telomerase activity in non-small cell lung cancer prognosis: clinical usefulness of a specific telomere status

    Journal of Experimental and Clinical Cancer Research, Vol. 34, Núm. 1

2014

  1. Carcinoma broncogénico no microcítico resecado, estadio pIIIA-N2: ¿En qué pacientes la adyuvancia ofrece mayor beneficio?

    Cirugia Espanola, Vol. 92, Núm. 4, pp. 277-282

2012

  1. Differential expression of senescence and cell death factors in non-small cell lung and colorectal tumors showing telomere attrition

    Oncology, Vol. 82, Núm. 3, pp. 153-164

  2. Methylation profiling in non-small cell lung cancer: Clinical implications

    International Journal of Oncology, Vol. 40, Núm. 3, pp. 739-746

  3. Video-Assisted Thoracoscopic Lung Biopsy in the Diagnosis of Interstitial Lung Disease: A Prospective, Multi-Center Study in 224 Patients

    Archivos de Bronconeumologia, Vol. 48, Núm. 3, pp. 81-85

2011

  1. More than one pulmonary resections or combined lung-liver resection in 79 patients with metastatic colorectal carcinoma

    Journal of Surgical Oncology, Vol. 104, Núm. 7, pp. 781-786

2009

  1. Tratamiento quirúrgico del cáncer de pulmón

    Revisiones en Cancer, Vol. 23, Núm. 4, pp. 140-150

2008

  1. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer

    Lung Cancer, Vol. 60, Núm. 3, pp. 416-425

2007

  1. Biological and clinical significance of MMP-2, MMP-9, TIMP-1 and TIMP-2 in non-small cell lung cancer

    Oncology Reports, Vol. 17, Núm. 1, pp. 217-223